Front Row: SABCS 2025 Insights with Dr. Francisco Esteva
Join host Victoria Goldberg and Dr. Francisco Esteva as they break down the groundbreaking research from the San Antonio Breast Cancer Symposium 2025. Discover the latest advances in metastatic breast cancer treatment, including new first-line therapies for HER2-positive disease with 40-month progression-free survival, oral SERDs revolutionizing hormone receptor-positive treatment, and antibody drug conjugates transforming triple-negative breast cancer care. Dr. Esteva shares expert insights on brain metastasis prevention, liquid biopsy-guided therapy switching, and how artificial intelligence is reshaping oncology. Whether you're a patient, caregiver, or healthcare professional, this episode offers hope and practical information about the cutting-edge treatments available in 2026.
Future at Risk: Why We Can’t Turn Back Now with Josh Newby
In this episode, co-hosts Victoria Goldberg and Martha Carlso are joined by Josh Newby, Founder and Executive Director of Theresa’s Research Foundation (TRF), for an in-depth conversation about the evolving landscape of metastatic breast cancer research and advocacy. Josh shares the origins and mission of his foundation, the challenges faced in funding and organizing medical conferences, and the shift toward curative approaches for metastatic breast cancer. The discussion covers the impact of recent funding cuts, the importance of collaboration among institutions and industry partners, and the critical role of patient advocates. The group also explores the realities of grant funding, the effects of political and economic changes on research, and the need for credible information and community support for patients. Throughout, the conversation highlights the resilience and determination required to push forward in the face of uncertainty, emphasizing the message: we can’t turn back now.
Fighting for Patients: Dr. Rebecca Shatsky on Insurance, Burnout, and Hope in MBC
Dr. Rebecca Shatsky, Director of Breast Medical Oncology at UC San Diego, shares her experiences fighting for patients with breast cancer. In this episode, Dr. Shatsky discusses the growing challenges clinicians face—from insurance denials and funding cuts to the emotional toll of burnout and the spread of cancer misinformation.
Hear real stories about advocating for life-saving treatments, navigating the complexities of clinical trials, and the importance of patient empowerment. Dr. Shatsky also offers hope, highlighting the latest breakthroughs in metastatic breast cancer research and the progress being made in treatment options.
Whether you’re a patient, caregiver, or healthcare professional, this episode delivers candid insights, practical advice, and a message of resilience and hope in the face of adversity.
Podcasters Roundtable: Samira Daswani, Host of The Patient from Hell
In this episode, hosts Victoria Goldberg and Abigail Johnston sit down with Samira Daswani, host of "The Patient From Hell" podcast, for a candid and insightful conversation about patient advocacy, storytelling, and the evolving landscape of cancer care. Samira shares her path from reluctant podcast guest to passionate host, highlighting the importance of amplifying patient voices and democratizing information for those navigating cancer diagnoses—especially in communities where open discussion is rare.
The discussion delves into the challenges of reaching diverse audiences, the power of authentic, minimally edited conversations, and the need for both scientific and personal perspectives in patient-centered content. The trio reflects on the shifting attitudes in cancer communities, the critical role of support networks, and the ongoing mission to educate and empower patients worldwide. The episode wraps up with ideas for future collaborations and a shared commitment to making a meaningful impact through storytelling and advocacy.
Live Chat: SERD Surge with Dr. Sherry Shen
Host Victoria, with Dr. Sherry Shen and co-host Ellen, delivers a concise, patient-focused overview of oral SERDs in HR+ metastatic breast cancer—covering ESR1 mutations, key trials (evERA, SERENA‑6), FDA‑approved agents, side-effect management, and treatment implications. This is the first episode in our Live Chats series. Bonus clip: Rebecca Shatsky, MD, previews the evERA trial and her excitement about combining capivasertib with oral SERDs.
Future at Risk: Protecting Research, Protecting Lives
What if the decades of progress against cancer — the breakthroughs, the rising survival rates, the new vaccines and cutting‑edge therapies — were suddenly put in jeopardy? Five decades after the “war on cancer” began, the hard‑won momentum now faces existential threats: canceled grants and clinical trials, proposals to slash the NCI budget, and an unprecedented politicization of biomedical research funding.
Victoria Goldberg is joined by Pam Traxel, Senior Vice President at the American Cancer Society and a lifelong patient advocate.
Future at Risk: About Us, MBC, and the Role of Research
In this powerful panel episode, hosts Victoria Goldberg and Abigail Johnston are joined by Dr. Jill Tirabassi and Alexis Desai—each bringing their unique perspective as patients, advocates, and experts living with metastatic breast cancer (MBC). Together, they share personal stories about navigating diagnosis, the critical role of research in extending lives, and the real-world challenges of accessing clinical trials.
The conversation dives deep into why research funding matters, how advocacy can drive change, and the urgent need for patient-centered care. Whether you’re a patient, caregiver, or ally, this episode offers insight, hope, and a call to action for everyone invested in the future of cancer research.
Tune in to hear firsthand experiences, learn about the latest advocacy efforts, and discover how you can help move the needle for those living with MBC.